REQUEST A DEMO
Total
USD $0.00
Search more companies

Raddisun Pharmachem Industries Private Limited (India)

Main Activities: Basic Chemical Manufacturing
Full name: Raddisun Pharmachem Industries Private Limited Profile Updated: January 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Raddisun Pharmachem Industries Private Limited is an enterprise in India, with the main office in Mumbai. It operates in the Basic Chemical Manufacturing industry. The company was established on February 18, 2012. In its most recent financial highlights, the company reported a net sales revenue drop of 41.03% in 2025. Its’ total assets recorded a negative growth of 79.71%. In 2025, Raddisun Pharmachem Industries Private Limited’s net profit margin increased by 0.52%.

Legal Address
Gala No A33, 2 Nd Floor Nand Dham Industrial Estate , Marol-Morashi Road
Mumbai; Maharashtra; Postal Code: 400059

Contact Details: Purchase the Raddisun Pharmachem Industries Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Raddisun Pharmachem Industries Private Limited report to view the information.
Financial Auditors:
Purchase the Raddisun Pharmachem Industries Private Limited report to view the information.
Incorporation Date:
February 18, 2012
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Raddisun Pharmachem Industries Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-41.03%
Total Operating Revenue
-40.87%
Operating Profit
147.77%
EBITDA
163.57%
Net Profit/Loss for the Period
157.55%
Total Assets
-79.71%
Total Equity
5.88%
Operating Profit Margin
0.78%
Net Profit Margin
0.52%
Return on Equity (ROE)
3.27%
Debt / Equity
11%
Quick Ratio
0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?